6533b827fe1ef96bd1285cfe

RESEARCH PRODUCT

Predictors of leptin concentration and association with cardiovascular risk in patients with coronary artery disease: results from the AtheroGene study

Dirk WestermannRenate B. SchnabelChristoph BickelChristoph SinningStefan BlankenbergTanja ZellerHans J. RupprechtKarl J. Lackner

subject

LeptinMalemedicine.medical_specialtyHealth Toxicology and MutagenesisClinical BiochemistryMyocardial Infarction030209 endocrinology & metabolismCoronary Artery DiseaseWhite adipose tissue030204 cardiovascular system & hematologyRisk AssessmentBiochemistryCohort StudiesCoronary artery disease03 medical and health sciencesSex Factors0302 clinical medicinePredictive Value of TestsInternal medicinemedicineHumansMyocardial infarctionAgedProportional Hazards ModelsProportional hazards modelbusiness.industryLeptinHazard ratioMiddle Agedmedicine.diseaseCardiovascular DiseasesPredictive value of testsCardiologyFemalebusinessFollow-Up StudiesCohort study

description

AbstractContext: Leptin is produced in white adipose tissue, but also in human coronary atherosclerotic lesions.Objective: The aim of this study is to assess the prognostic value of leptin in patients with proven coronary artery disease (CAD) (N = 1907).Methods: AtheroGene is a contemporary CAD cohort study (N = 3229). Median follow-up time was 3.8 (Quartile 1/3 with 2.8/4.9) years.Results: Leptin concentration was associated with a hazard ratio (HR) for the fully adjusted model of HR = 1.32 in women but was not significant in men. The endpoint cardiovascular death and non-fatal myocardial infarction was observed in 167 patients.Conclusion: In women with known CAD, increased leptin concentration is useful for predicting cardiovascular death and non-fatal myocardial infarction.

yearjournalcountryeditionlanguage
2016-01-15Biomarkers
https://doi.org/10.3109/1354750x.2015.1130745